Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience

NCT06857500 · clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Federico II University